Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 104 citing Hurst: Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms.... (0.09 sec) 

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

- shouxi.net
A Dibra, A Kastrati, J Mehilli, J Pache, H … - The New England journal of medicine, 2005 - nejm.highwire.org
Methods We enrolled 250 patients with diabetes and coronary artery disease: 125
were randomly assigned to receive paclitaxel-eluting stents, and 125 to receive
sirolimus-eluting stents. The primary end point was in-segment late luminal ...
Cited by 315 - Related articles - BL Direct - All 13 versions

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated …

- uchicago.edu [PDF] 
JB Kostis, AC Wilson, RS Freudenberger, NM … - The American journal of cardiology, 2005 - Elsevier
Diuretic-based antihypertensive therapy is associated with the development of
diabetes but with improved clinical outcomes. It has been proposed that the
duration of clinical trials has been too short to detect the adverse ...
Cited by 122 - Related articles - All 7 versions

Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes

- diabetesjournals.org
DJ Wexler, RW Grant, JB Meigs, DM Nathan, … - Diabetes Care, 2005 - Am Diabetes Assoc
RESULTS—Women were less likely than men to have HbA 1c <7% (without CHD: AOR
0.84 [95% CI 0.75–0.95], P = 0.005; with CHD: 0.63 [0.53–0.75], P < 0.0001).
Women without CHD were less likely than men to be treated with ...
Cited by 81 - Related articles - All 10 versions

The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study.


VG Athyros, VI Bouloukos, AN Pehlivanidis, … - Diabetes, Obesity & Metabolism, 2005 - pt.wkhealth.com
Background: The Third Report (ATP III) of the National Cholesterol Education
Program Expert Panel (NCEP) highlighted the importance of identifying and
treating patients with the metabolic syndrome (MetS) to prevent ...
Cited by 74 - Related articles - All 5 versions

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction

- diabetesjournals.org
SE Inzucchi, FA Masoudi, Y Wang, M … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We conducted a retrospective cohort study of
24,953 Medicare beneficiaries with diabetes discharged after hospitalization
with AMI between April 1998 and March 1999 or July 2000 and June 2001. The ...
Cited by 53 - Related articles - BL Direct - All 5 versions

Poly (ADP-ribose) polymerase contributes to the development of myocardial infarction in …

- aspetjournals.org
CY Xiao, M Chen, Z Zsengeller, C Szabo - Journal of Pharmacology and Experimental …, 2004 - ASPET
Activation of the nuclear enzyme poly(ADP-ribose) polymerase (PARP)-1 by
oxidant-mediated DNA damage is an important pathway of cell dysfunction and
tissue injury during myocardial infarction. Because diabetes mellitus can ...
Cited by 37 - Related articles - BL Direct - All 8 versions

Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 …


BK Irons, RS Greene, TA Mazzolini, KL … - Pharmacotherapy, 2006 - PPI
Brian K. Irons, Pharm.D., Ronald Shane Greene, Pharm.D., Timothy A. Mazzolini,
Pharm.D., Krystal L. Edwards, Pharm.D., and Rebecca B. Sleeper, Pharm.D. ...
Clinical data suggest that thiazolidinediones—specifically, rosiglitazone ...
Cited by 27 - Related articles - BL Direct - All 3 versions

A prospective study of depression and mortality in patients with type 2 diabetes: the …


DG Bruce, WA Davis, SE Starkstein, TME … - Diabetologia, 2005 - Springer
Abstract Aims/hypothesis: Depression is associated with excess mortality in
patients with type 2 diabetes. We inves- tigated the impact, and possible causal
mechanisms, of depression on all-cause and cardiac mortality in patients ...
Cited by 27 - Related articles - BL Direct - All 4 versions

Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome


E Rizos, AP Tambaki, I Gazi, AD Tselepis, M … - Prostaglandins, Leukotrienes & Essential Fatty Acids, 2005 - Elsevier
Plasma- and lipoprotein-associated activity of the platelet activating factor
acetylhydrolase (PAF-acetylhydrolase, PAF-AH) plays an important role in
inflammation and in atherosclerotic process, which are present in the ...
Cited by 24 - Related articles - All 12 versions

Preserved glucoregulation but attenuation of the vascular actions of insulin in mice …

- diabetesjournals.org
SB Wheatcroft, AM Shah, JM Li, E Duncan, … - Diabetes, 2004 - Am Diabetes Assoc
Type 2 diabetes is preceded by years of insulin resistance and is characterized
by reduced bioavailability of the antiatherosclerotic signaling molecule nitric
oxide (NO) and premature atherosclerosis. The relationship between ...
Cited by 20 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google